Anti-MYMX antibodies are used in the immunodetection of the protein myomixer, myoblast fusion factor. In humans, the canonical protein has a reported length of 84 amino acid residues and a mass of 9.6 kDa. Its subcellular localization is in the cell membrane. It is notably expressed in the skeletal muscle. A member of the MYMX protein family, Mymx is reported to be a myoblast-specific protein that mediates myoblast fusion, an essential step for the formation of multi-nucleated muscle fibers. The MYMX gene has been associated with the disease, Carey-Fineman-Ziter syndrome. Synonyms for this target antigen include microprotein inducer of fusion, myomerger, protein minion, and protein myomixer. MYMX gene orthologs have been reported in the mouse, rat, bovine, chimpanzee and chicken species. A number of Mymx antibodies have been mentioned in research publications and have associated citations. Indicated applications for the antibodies listed below include ELISA, Western Blot, Immunocytochemistry, Immunofluorescence, and Immunohistochemistry.